Prepandemic influenza vaccine (H5N1) (whole virion, inactivated,prepared in cell culture, Nanotherapeutics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePrepandemic influenza vaccine (H5N1) (whole virion, inactivated,prepared in cell culture, Nanotherapeutics)
Drug Alias NameH5N1全病毒粒子灭活疫苗大流行前流感疫苗Vepacel
ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Inactivated vaccine > Whole microorganism inactivated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2012/02/17
Country/TerritoryAustriaGermanyEU
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesBaxter International Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeJ07BB01
Related LinksN/A